CardiologyOnline.net

Cardiology Xagena

Physicians have long touted the short- and long-term health benefits of breastfeeding, but a research has shown it also may reduce a woman’s risk of having a myocardial infarction or stroke later in l ...


Results from the global phase III CANTOS study investigating the efficacy, safety and tolerability of Canakinumab ( ACZ885 ) in combination with standard of care in people with a prior myocardial inf ...


A new study by researchers at the Intermountain Medical Center Heart Institute in Salt Lake City found that using long-term Aspirin ( Acetylsalicylic acid ) therapy to prevent strokes among patients w ...


As the Zika virus continues to spread globally, new evidence has emerged about the virus's potentially detrimental effects on the heart. The study included adult patients with no prior history of c ...


Evolocumab ( Repatha ), a PCSK9 inhibitor, has shown to dramatically lower levels of low-density lipoprotein ( LDL), and also the risk of cardiovascular events in patients with existing heart or vascu ...


Amid growing uncertainty about the safety of Digoxin, a commonly used heart drug, a study led by Duke Clinical Research Institute found that people with atrial fibrillation should avoid taking the dru ...


Findings from a real-world data analysis of the U.S. Medicare database comparing the risk of stroke or systemic embolism and rate of major bleeding among patients with non-valvular atrial fibrillation ...


Although studies have examined the association between dietary Magnesium intake and health outcome, the results are inconclusive. Researchers have conducted a dose–response meta-analysis of prospect ...


Although there are many different antiarrhythmic drugs approved for rhythm management of atrial fibrillation, little comparative effectiveness data exist to guide drug selection. Researchers follow ...


Catheter ablation of ventricular tachycardia in patients with nonischemic dilated cardiomyopathy can be challenging because of the complexity of underlying substrates. Researchers sought to determin ...


Randomized controlled trials ( RCTs ) regarding use of Ranolazine for the prevention and cardioversion of atrial fibrillation have yielded conflicting results. Researchers have conducted a meta-ana ...


Available pharmacological options for rhythm control strategy in atrial fibrillation are limited by sub-optimal efficacy and potentially serious adverse events. The aim of meta-analysis was to det ...


The optimal rhythm management strategy for people with non-paroxysmal ( persistent or long-standing persistent ) atrial fibrilation is currently not well defined. Antiarrhythmic drugs have been the ...


Ondansetron ( Zofran ) is commonly used to treat vomiting in gastroenteritis, but has a United States FDA ( Food and Drug Administration ) black box warning for risk of Q wave to T wave time interval ...


A study has examined patients with chronic kidney disease ( CKD ) in stages 1, 2, 3 and 4, left ventricular dysfunction and automatic implantable cardioverter-defibrillator ( ICD ). The goal was to ...